493 results
8-K
EX-99
PFE
Pfizer Inc.
1 May 24
Pfizer Reports First-Quarter 2024 Results
8:11am
health outcomes in medically underrepresented communities across the U.S. by enhancing awareness of and access to cancer screenings, clinical trial … affecting, among other things, pharmaceutical product pricing, intellectual property, reimbursement or access or restrictions on U.S. direct-to-consumer
PX14A6G
Tara Health Foundation
16 Apr 24
Letter to shareholders
10:19am
women, ensure equal opportunities for leadership and access to reproductive health.” Such a report should identify and explain trends of incongruent … support this proposal because it is apparent that many recipients of the Company’s political contributions are working actively to undermine access
S-3ASR
PFE
Pfizer Inc.
23 Feb 24
Automatic shelf registration
4:34pm
with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.
We
8-K
EX-99
7xauu8i
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K
EX-99.1
wbb 7nmvnvp787
10 Jan 24
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
4:38pm
8-K/A
EX-99.1
f61po1j1hniyozx6i6
14 Dec 23
Pfizer Completes Acquisition of Seagen
5:04pm
8-K
EX-99.1
vmkh 0t3nn
14 Dec 23
Pfizer Completes Acquisition of Seagen
7:51am
8-K
EX-99.1
z9xk98rbea8p5chzyueu
13 Dec 23
Full-Year 2024 Revenue Guidance(1) Range of $58.5 to $61.5 Billion Includes Expected Contribution from Seagen Acquisition
7:44am
8-K
EX-99.1
qbikgeeodt8ovz4 hzy6
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
EX-99
a3vv2nwq
31 Oct 23
Pfizer Reports Third-Quarter 2023 Results
8:04am
8-K
6175brt dmfz
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm
8-K
EX-99
b4h0zdnu7t2l8e
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm
8-K
EX-99
lc19objdf2tc704f2by8
1 Aug 23
Pfizer Reports Second-Quarter 2023 Results
8:09am
8-K
EX-1.1
kkv903np0ysv k6ac3k
19 May 23
Other Events
4:26pm